Published in Drug Metab Dispos on December 08, 2010
Positive allosteric modulation of α4β2 nicotinic acetylcholine receptors as a new approach to smoking reduction: evidence from a rat model of nicotine self-administration. Psychopharmacology (Berl) (2013) 0.85
Dose-dependent sigma-1 receptor occupancy by donepezil in rat brain can be assessed with (11)C-SA4503 and microPET. Psychopharmacology (Berl) (2014) 0.82
Age-Related Decline in Brain and Hepatic Clearance of Amyloid-Beta is Rectified by the Cholinesterase Inhibitors Donepezil and Rivastigmine in Rats. ACS Chem Neurosci (2015) 0.80
Donepezil, an acetylcholinesterase inhibitor, attenuates nicotine self-administration and reinstatement of nicotine seeking in rats. Addict Biol (2012) 0.80
In silico predictive model to determine vector-mediated transport properties for the blood-brain barrier choline transporter. Adv Appl Bioinform Chem (2014) 0.79
Repeated administration of an acetylcholinesterase inhibitor attenuates nicotine taking in rats and smoking behavior in human smokers. Transl Psychiatry (2016) 0.79
A novel acetylcholinesterase inhibitor and calcium channel blocker SCR-1693 improves Aβ25-35-impaired mouse cognitive function. Psychopharmacology (Berl) (2015) 0.75
Enduring effects of tacrine on cocaine-reinforced behavior: Analysis by conditioned-place preference, temporal separation from drug reward, and reinstatement. Pharmacol Res (2015) 0.75
Microvascular structure and network in the retina of patients with ischemic stroke. Stroke (2013) 1.08
Astroglia-mediated effects of uric acid to protect spinal cord neurons from glutamate toxicity. Glia (2007) 1.03
The prognostic effects of poststroke cognitive impairment no dementia and domain-specific cognitive impairments in nondisabled ischemic stroke patients. Stroke (2011) 0.98
Is uric acid protective or deleterious in acute ischemic stroke? A prospective cohort study. Atherosclerosis (2009) 0.98
Cognitive enhancing effects of ghrelin receptor agonists. Psychopharmacology (Berl) (2009) 0.97
Alternative method of oral dosing for rats. J Am Assoc Lab Anim Sci (2010) 0.94
Selective loss of P2Y2 nucleotide receptor immunoreactivity is associated with Alzheimer's disease neuropathology. J Neural Transm (Vienna) (2008) 0.91
Investigation of the drug-drug interaction between alpha-lipoic acid and valproate via mitochondrial beta-oxidation. Pharm Res (2008) 0.87
Altered NCAM expression associated with the cholinergic system in Alzheimer's disease. J Alzheimers Dis (2010) 0.84
Upregulation of AMPA receptor GluR2 (GluA2) subunits in subcortical ischemic vascular dementia is repressed in the presence of Alzheimer's disease. Neurochem Int (2011) 0.83
Intact cannabinoid CB1 receptors in the Alzheimer's disease cortex. Neurochem Int (2010) 0.82
Metabonomic profiling of TASTPM transgenic Alzheimer's disease mouse model. J Proteome Res (2012) 0.82
Hippocampal neurofibrillary tangle changes and aggressive behaviour in dementia. Neuroreport (2010) 0.82
Involvement of the GABAergic system in depressive symptoms of Alzheimer's disease. Neurobiol Aging (2005) 0.81
Arterial stiffness is associated with intracranial large artery disease among ethnic Chinese and South Asian ischemic stroke patients. J Hypertens (2009) 0.80
Involvement of an altered 5-HT -{6} receptor function in behavioral symptoms of Alzheimer's disease. J Alzheimers Dis (2008) 0.80
Metabolic profiling of 3-nitropropionic acid early-stage Huntington's disease rat model using gas chromatography time-of-flight mass spectrometry. J Proteome Res (2011) 0.79
A serotoninergic basis for hyperphagic eating changes in Alzheimer's disease. J Neurol Sci (2009) 0.79
Differential involvement of hippocampal serotonin1A receptors and re-uptake sites in non-cognitive behaviors of Alzheimer's disease. Psychopharmacology (Berl) (2010) 0.79
Preservation of cortical histamine H3 receptors in ischemic vascular and mixed dementias. J Neurol Sci (2011) 0.78
iTRAQ quantitative clinical proteomics revealed role of Na(+)K(+)-ATPase and its correlation with deamidation in vascular dementia. J Proteome Res (2014) 0.78
Decreased immunoreactivities of neocortical AMPA receptor subunits correlate with motor disability in Lewy body dementias. J Neural Transm (Vienna) (2013) 0.76
Orally bioavailable and brain-penetrant pyridazine and pyridine-derived γ-secretase modulators reduced amyloidogenic Aβ peptides in vivo. Neuropharmacology (2013) 0.76
Growth differentiation factor-15 and white matter hyperintensities in cognitive impairment and dementia. Medicine (Baltimore) (2016) 0.76
A sensitive LC/MS/MS bioanalysis assay of orally administered lipoic acid in rat blood and brain tissue. J Pharm Biomed Anal (2009) 0.75
In vivo 5-HT(6) receptor occupancy by antipsychotic drugs in the rat brain. Neurosci Lett (2011) 0.75
Metabolic profiling of rat brain and cognitive behavioral tasks: potential complementary strategies in preclinical cognition enhancement research. J Proteome Res (2009) 0.75